Advertisement
Advertisement
VERU
Veru Inc.
2.33
USDSponsored
+0.02
+0.87%
Aug 07, 15:59 UTC -4
Closed
After-Market
2.36
+0.03
+1.24%
VERU Earnings Reports
Positive Surprise Ratio
VERU beat 20 of 36 last estimates.
56%
Next Report
Next Week
Date of Next Report
Aug 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.32
Implied change from Q2 26 (Revenue/ EPS)
--
/+166.67%
Implied change from Q3 25 (Revenue/ EPS)
--
/-36.00%
Veru Inc. earnings per share and revenue
On May 13, 2026, VERU reported earnings of -0.12 USD per share (EPS) for Q2 26, beating the estimate of -0.29 USD, resulting in a 58.72% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.44% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an increase of 166.67% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
Cytosorbents Corp.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Prestige Consumer Healthcare Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.89
Actual
$0.98
Surprise
+10.01%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
FAQ
What were Veru Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Veru Inc. reported EPS of -$0.12, beating estimates by 58.72%, and revenue of $0.00, 0% as expectations.
How did the market react to Veru Inc.'s Q2 2026 earnings?
The stock price moved down -0.44%, changed from $2.27 before the earnings release to $2.26 the day after.
When is Veru Inc. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Veru Inc.'s next earnings report?
Based on 4
analysts, Veru Inc. is expected to report EPS of -$0.32 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement